Cephalic Femoral Heads Follow Up

Study design: monocentric, retrospective, observational and post-market clinical study. Purpose: To demonstrate the safety and performance of cephalic femoral heads. The eligible study population is represented by the entire population that underwent a hip replacement with cephalic femoral heads from 1st January 2023 onwards at the site in accordance with the indication for use of the product.

NCT Number	NCT06873568
Lead Sponsor	Limacorporate S.p.a
Conditions	Hip Arthroplasty Replacement, Femoral Fractures
Enrollment	47 participants
Start Date	2025-10
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-03-18